RJ PHARMACEUTICAL LIMITED

RJ PHARMACEUTICAL LIMITED

Statement of Financial Position

As at 30 April 2026

	2026 £		2025 £
Fixed assets		2,299		1,979
Current assets	67,835		123,620
Creditors: amount falling due within one year	(2,063)		(26,180)
Net current assets/(liabilities)		65,772		97,440
Total assets less current liabilities		68,071		99,419
Net assets/(liabilities)		68,071		99,419


Capital and reserves		68,071		99,419

Notes to the Accounts

Statutory Information

Rj Pharmaceutical Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 14820134, registration address Apollo House, Hallam Way, Whitehills Business Park, Blackpool, FY4 5FS, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the year was 1 (2025: 1).

3.	Director Advances Credits Note At 30th April 2026 the director owed RJ Pharmaceutical Limited £1,084,54 (£82.54 at 30th April 2025). The loan is interest-free, unsecured and has no set repayment terms.

Director's Responsibilities:

For the year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

---------------------------------------------

Rachel Ellen Jones
Director

Date approved: 16 October 2026